ambrisentan
ambrisentan is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including ambrisentan, Ambrisentan. Available dosage form: tablet, film coated.
Drug details
- Generic Name
- ambrisentan
- Brand Names
- ambrisentan, Ambrisentan
- Application Number
- ANDA210784
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- NDC Codes
- 8
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- AMBRISENTAN
Indications and Usage
1 INDICATIONS AND USAGE Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%). Ambrisentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included trials predominantly in patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%) ( 1 ).